Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

View basket
☰

Eldepryl

Eldepryl
In stock
5mg · 10mg
from 24,90 £
Strength
Pack size — the bigger the pack, the cheaper the tablet
32,59 £27,16 £
0,91 £ per tablet

In brief

  • In most countries (including the UK, US and EU) eldepryl (selegiline) is a prescription-only medicine and is supplied via pharmacies or hospital prescriptions; brand suppliers include Somerset Pharmaceuticals (US) and Sovereign Medical (UK) and multiple generic suppliers globally — note some online or local pharmacies may offer it without a prescription, but such purchases can be illegal and carry safety risks.
  • Eldepryl is used mainly as an adjuvant treatment for Parkinson’s disease; it is a selective monoamine oxidase B (MAO-B) inhibitor that increases central dopamine availability and may help reduce “wearing-off” symptoms when used with levodopa/carbidopa.
  • The usual adult dose for Parkinson’s is 5–10 mg daily (commonly 5 mg twice daily); orally disintegrating tablets (ODT) are used at lower strengths (about 1.25–2.5 mg once daily). Doses may be adjusted when used with levodopa.
  • Administration forms include oral tablets (5 mg, 10 mg), capsules (5 mg), orally disintegrating tablets (Zelapar 1.25 mg) and transdermal patches (other selegiline preparations such as Emsam); Eldepryl is usually given orally as tablet or capsule.
  • Pharmacological action begins within hours of a dose, but meaningful symptomatic improvement for Parkinson’s disease is often noticed over days to several weeks of treatment.
  • Although the plasma half-life of selegiline is relatively short, its irreversible inhibition of MAO‑B produces effects that persist for about 24 hours after dosing; transdermal formulations provide continuous 24‑hour delivery.
  • Avoid excessive alcohol while taking selegiline: alcohol can worsen dizziness, drowsiness and orthostatic effects and some alcoholic/fermented drinks may be high in tyramine, increasing the risk of hypertensive reactions.
  • The most common side effect is nausea; other frequent adverse effects include dry mouth, dizziness, insomnia, headache, abdominal pain and increased sweating.
  • Would you like to try eldepryl without a prescription?

Market Realities And UK Availability Of Eldepryl

Basic Eldepryl Information

  • INN (International Nonproprietary Name): Selegiline (also known as Selegilina, Selegilinum, L-Deprenalin).
  • Brand Names Available In United Kingdom: Eldepryl — tablets 5 mg and 10 mg supplied in blister packs of 28 or 100.
  • ATC Code: N04BD01 (Monoamine oxidase B inhibitors; anti-parkinson drugs).
  • Forms & Dosages: Tablets 5 mg and 10 mg (blisters 28, 100); capsules 5 mg; orally disintegrating tablets 1.25 mg (Zelapar); transdermal patches 6, 9, 12 mg/24 hr (Emsam) — where relevant.
  • Manufacturers In United Kingdom: Sovereign Medical is listed as a United Kingdom supplier.
  • Registration Status In United Kingdom: Prescription only; approved and registered for use in anti‑parkinson treatment by major regulatory agencies including MHRA.
  • OTC / Rx Classification: Prescription only (Rx) in the United Kingdom.

Retail Landscape And Supply

Where can patients usually get Eldepryl in the UK and what should pharmacies expect?

Eldepryl sits in a specialised retail niche as a prescription-only MAO‑B inhibitor used mainly in Parkinson’s disease.

Many patients obtain selegiline after GP or neurologist prescription, dispensed at high-street chains such as Boots, LloydsPharmacy and Superdrug or via registered online pharmacies.

Electronic prescriptions and home delivery are increasingly common across the retail landscape.

Stock keeping benefits from the known pack sizes — 5 mg and 10 mg tablets in blisters of 28 or 100 — for ordering and inventory control.

Regional funding matters for accessibility and cost to the patient.

Prescriptions are free for eligible groups in Scotland, Wales and Northern Ireland, while in England standard prescription charges may apply or be covered by exemptions.

Private price variance exists between NHS prescription charge, private clinic supply and online wholesalers; specific retail price bands are not specified in the product data.

Pharmacies should flag stockouts quickly and offer approved generics labelled as selegiline or Selegilina to maintain continuity.

NHS Versus Private Access

How does NHS access compare to private supply in practice?

Access Route Typical Expectation Typical Wait/Delivery Time
NHS Prescription (England) Prescription from GP or neurologist, dispensed at community pharmacy or hospital pharmacy. Usually same-day to 3 days depending on stock and local pharmacy.
NHS Prescription (Scotland/Wales/Northern Ireland) Prescription charges vary by region and exemption status; collection from local pharmacy. Usually same-day to 3 days depending on stock and local pharmacy.
Private Clinic Supply Prescriber issues private prescription; patient pays privately. 2–7 days depending on clinic dispensing and courier.
Online Pharmacy (Private Supply) Private supply via registered online pharmacies; discreet delivery options available. Delivery typically 5–14 days for some services; check vendor timelines.

Note: In our online pharmacy, eldepryl is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Patient Experiences, Adherence And Real-World Issues

Typical Patient Journeys

What does a typical patient journey on Eldepryl look like?

Common journeys start with a GP referral to neurology when Parkinson’s symptoms affect daily living.

Neurologists may trial selegiline as an adjunct to levodopa/carbidopa to manage early motor fluctuations or delay levodopa escalation.

Typical starting regimens use a low selegiline dose with gradual upward titration while monitoring symptoms and side effects.

Patients collect medication from community pharmacies or receive home delivery from registered online services.

Regular follow-up appointments or medicines reviews are scheduled to check efficacy, tolerability and interactions with other Parkinson’s medicines.

Common real-world benefits reported by patients include reduced “wearing-off” and steadier on-time with levodopa use.

Some patients report modest benefit while others require combination therapy adjustments.

Adherence Barriers And Support

What stops people taking Eldepryl as prescribed and how can pharmacy teams help?

  • Common patient concerns: insomnia, dry mouth, dizziness and increased sweating.
  • Polypharmacy and pill burden with levodopa/carbidopa and other agents raise adherence issues in older adults.
  • Scheduling doses incorrectly (evening dosing causing insomnia) is a frequent practical problem.
  • Pharmacists should offer structured medicines reviews and synchronise prescriptions where possible.
  • Practical aids include reminder apps, multicompartment compliance aids and clear printed leaflets on tyramine food cautions.

Checklist For Pharmacists To Assess Adherence:

  • Ask about timing of doses and sleep disturbance.
  • Confirm other medicines that might interact, including SSRIs and opioids.
  • Document any dizziness, falls or hallucinations since starting selegiline.
  • Offer ODT advice if swallowing is difficult and check for suitability of Zelapar when prescribed.

Indications And Practical Use Cases In Pharmacy

Licensed Indications (UK-Focused)

How should Eldepryl be presented on a pharmacy product page for clinicians and patients?

Adjunctive Treatment For Parkinson’s Disease
Typical Dose: 5–10 mg daily, often 5 mg twice daily.
Expected Effect: Improved dopaminergic tone and delay in levodopa dose escalation.
Monitoring: Review at 2–6 weeks for symptomatic response and side effects.
With Levodopa/Carbidopa
Typical Dose: Same as above with dose adjustments of levodopa as required.
Expected Effect: Reduced wearing-off episodes.
Monitoring: Check for increased dyskinesia and orthostatic hypotension.

Off-Label And Related Uses To Present With Care

What off-label uses might patients ask about and how should pharmacists respond?

Depression (Transdermal Selegiline)
Notes: Transdermal formulations (Emsam) have been used in depressive disorders but this is not typical for Eldepryl tablets.
Action: Refer queries to prescriber and avoid offering off-label advice without clinical oversight.
Investigational Uses
Notes: Some agents in the class have research-level indications; always advise referral to neurology or GP.

Always direct off-label enquiries back to the prescriber and document advice given.

Product Forms, Dosages And Packaging (Shop-Ready Detail)

Forms Sold And Strengths

What stock should a retail pharmacy expect to list on product pages and order from wholesalers?

Form Strengths Typical Packaging
Tablet 5 mg, 10 mg Blister packs 28, 100
Capsule 5 mg Blister packs (variable)
Orally Disintegrating Tablet (Zelapar) 1.25 mg Blister packs
Transdermal Patch (Emsam) 6, 9, 12 mg/24 hr Patches

Practical Dispensing Notes

What should dispensary staff check before handing out Eldepryl?

  • Check prescription status and confirm brand or generic preference with prescriber if substitution is considered.
  • Counsel on dosing schedules — commonly 5 mg twice daily for tablets, ODT dosing differs (1.25–2.5 mg once daily).
  • Do not crush or chew tablets unless product is an ODT formulation designed to dissolve on the tongue.
  • Inspect blister integrity and expiry dates and ensure labelling emphasises prescription-only status.
  • Check for contraindicated co-medications (e.g. other MAOIs, certain opioids) and relevant allergies.

Practical Dosing Guidance And Titration

Standard Regimens For Parkinson’s

How are the commonly used doses best explained to patients?

Standard adult dosing for Parkinson’s disease is 5–10 mg daily, most often split as 5 mg twice daily when tablets or capsules are used.

For orally disintegrating formulations, typical doses are 1.25–2.5 mg once daily.

Pharmacy counselling should stress morning dosing when insomnia occurs and confirm whether the prescriber intended once‑daily or divided dosing.

Titration Schedules And Real-World Tips

Practical titration steps that pharmacy teams can relay to prescribers and patients:

Step Action
Start Begin at 5 mg once daily (or 1.25 mg ODT) and monitor for tolerance.
Up-Titrate Increase to 5 mg twice daily if needed after 2–4 weeks.
Max Consider up to 10 mg daily for tablets/capsules; document response and side effects.
Follow-Up Arrange review at 2–8 weeks and communicate any concerns to the prescriber.

Patient Counselling Points: do not stop abruptly, take ODT by dissolving on the tongue, move dosing to morning if insomnia develops, seek urgent care for severe hypertension or hallucinations.

Contraindications, Drug Interactions And Food Safety (Practical)

Absolute And Relative Contraindications

Contraindication Action Required
Hypersensitivity To Selegiline Or Excipients Do not dispense; advise prescriber and document allergy.
Concomitant Use With Other MAOIs Or Meperidine Contraindicated; contact prescriber urgently.
Pheochromocytoma Contraindicated due to hypertensive crisis risk.
Severe Cardiovascular Disease Use with caution; liaise with prescriber and monitor blood pressure closely.

Key Drug Interactions And Food Cautions

Which interactions and food cautions should be front-of-mind?

Warn about serotonergic agents such as SSRIs and SNRIs, and certain triptans because of serotonin syndrome risk when combined with selegiline.

Sympathomimetics and some anaesthetics require caution because of potential hypertensive effects.

Although selective MAO‑B inhibition reduces tyramine risk at usual doses, patients should still be aware of tyramine-rich foods such as aged cheese and cured meats to avoid hypertensive episodes.

Use a simple red/amber/green interaction triage in the dispensary to decide when to refer to the prescriber.

Side-Effect Profile, Monitoring And Pharmacist Actions

Common And Clinically Significant Adverse Effects

  • Common adverse effects include nausea, dry mouth, dizziness, insomnia, headache and increased sweating.
  • Clinically significant concerns include orthostatic hypotension, agitation and hallucinations, particularly in frail or polypharmacy patients.
  • Document any reports of behavioural change, falls or worsening cognition and relay to the prescriber.

Monitoring Schedule And Red Flags

What monitoring should pharmacy teams recommend and what triggers urgent action?

Baseline blood pressure assessment is useful where available, and routine check-ins at 2–4 weeks after starting or after dose changes are recommended.

Advise patients to seek urgent review for severe hypertension, agitation, convulsions or signs of serotonin syndrome such as rapid changes in mental status and high temperature.

Report suspected adverse reactions to the MHRA Yellow Card scheme and document the discussion in the patient record.

Combining Eldepryl With Levodopa And Polypharmacy Management

Practical Benefits And Pitfalls

Does combining selegiline with levodopa help and what should pharmacy teams watch for?

Eldepryl is commonly used as an adjunct to levodopa/carbidopa to reduce wearing-off and to allow lower levodopa doses where appropriate.

Benefits include smoother motor control and potential delay of levodopa escalation.

Pitfalls include possible increased dopaminergic side effects such as dyskinesia and compounded orthostatic hypotension when combined with antihypertensives.

Dosing Coordination With Levodopa/Carbidopa

Timeline Action
Baseline Record current levodopa dose and symptom pattern.
Introduce Eldepryl Start 5 mg once daily, review response in 2–6 weeks.
Adjustment Consider levodopa dose reduction if dyskinesia increases or to optimise benefit.
Follow-Up Offer pill synchronisation and compliance aids to improve adherence.

Common co-prescribed Parkinson’s drugs include dopamine agonists, COMT inhibitors and other MAO‑B inhibitors; any combination should prompt prescriber communication.

Dosing Adjustments: Elderly, Hepatic/Renal Impairment And Paediatrics

Age-Related Considerations

How should dosing differ for older patients?

Elderly patients may have increased sensitivity to selegiline and should usually start at the lower end of the adult dosing range with careful titration and close monitoring.

Watch for increased dizziness, sedation and hallucinations that may require dose reduction.

Consider ODT forms if swallowing difficulty is an issue and liaise with prescribers about suitability for compliance aids.

Organ Impairment And Special Populations

What about liver or kidney impairment and children?

Use selegiline with caution in hepatic or renal impairment because reduced clearance can increase exposure and adverse effects.

No paediatric dosing is established and use in children is not recommended.

Pharmacy checklist: verify recent renal and hepatic function where available, flag for dose review after any clinically relevant change and add an alert badge on the patient record to “start low, monitor closely”.

Storage, Transport, Handling And Expiry Guidance For Retail

Shelf-Life And Storage Conditions

Item Instruction
Storage Temperature Store in original packaging at room temperature below 25°C.
Moisture And Light Keep away from moisture and direct light; do not refrigerate or freeze.
Expiry Checks Rotate stock and remove any discoloured or damaged tablets from sale.

Pharmacy Handling And Patient Counselling

Dispensing staff should check blister integrity, batch numbers and expiry dates on receipt.

Advise patients to store medicines in original packs, keep out of reach of children and return unwanted medicines to the pharmacy for safe disposal.

Provide an emergency advice note outlining overdose signs such as severe hypertension, agitation or convulsions and instruct immediate medical attention.

Missed Dose, Overdose Management And Emergency Advice

Practical Missed-Dose Guidance

What should patients do if they miss a dose?

Take the missed dose as soon as remembered unless it is nearly time for the next scheduled dose.

Do not double up doses to make up for a missed dose.

Overdose Response And Triage

What to do if an overdose is suspected.

Overdose can cause severe hypertension, agitation, convulsions, hallucinations and potentially life-threatening complications.

Pharmacy triage checklist: if mild (single missed dose) provide routine advice; if suspected overdose call emergency services and provide details on dose taken, time and concomitant medications.

Emergency department actions typically include blood pressure control, benzodiazepines for agitation and monitoring for serotonin syndrome.

Document incidents and report suspected adverse reactions via the MHRA Yellow Card scheme.

Competitor Products, Formulary Positioning And Cost Comparisons

Key Alternatives And Comparative Notes

Product Mechanism Dosing Frequency Cost Band
Rasagiline MAO‑B inhibitor Once daily Not specified (varies through NHS/private supply)
Safinamide Reversible MAO‑B inhibitor Once daily Not specified
Entacapone COMT inhibitor With each levodopa dose Not specified

Formulary Inclusion And Cost Drivers In UK

Formulary placement often depends on clinical equivalence, dosing convenience, tolerability and acquisition cost.

Rasagiline’s once-daily dosing may favour adherence while selegiline remains a cost-effective, well-established option with multiple generics available from global suppliers.

Generics from manufacturers such as Sun Pharma, Mylan and Teva can reduce acquisition costs for pharmacies.

Regulatory Status, Manufacturers And Supply Chain Notes

Licensing And Regulatory Approvals (UK Focus)

What is the regulatory status of selegiline in the UK and elsewhere?

Selegiline is prescription only in the United Kingdom and is approved by major regulatory agencies including the MHRA.

It is classified under ATC code N04BD01 as an MAO‑B inhibitor for anti‑parkinson use.

Main Manufacturers And Procurement Tips

  • Suppliers and manufacturers include Sovereign Medical in the UK and global manufacturers such as Sun Pharma, Teva, Sandoz, Intas and Abbott.
  • Maintaining multi-supplier relationships reduces the impact of shortages.
  • Verify authentic packaging, batch numbers and supplier licences when procuring stock.
  • For international orders check lead times, customs implications and that tablets are stored in dry, room-temperature conditions during transit.

Product Page Template, SEO Elements And Pharmacy Merchandising

Essential On-Page Components For Eldepryl Product Page

What information converts browsers into customers while staying compliant?

  • Hero image with pack shot, clear INN: Selegiline and pack sizes.
  • Quick facts: prescription requirement badge, ATC code and short indication line for Parkinson’s adjunctive therapy.
  • Price band and NHS/private availability line (note local charges and prescription status).
  • “Ask A Pharmacist” contact button and downloadable patient leaflet (PDF).

SEO And FAQ Suggestions Tailored To UK Shoppers

Title tag example: Eldepryl 5 mg Tablets — Prescription Selegiline | [Pharmacy Name] UK.

Meta description should address NHS/private availability and discreet delivery options for private supply.

FAQ accordion should cover “Is Eldepryl available on NHS prescription?”, “How much does Eldepryl cost privately?” and “Can I switch to a generic selegiline?”.

Delivery Across United Kingdom

City Region Delivery time
London England 5-7 days
Birmingham England 5-7 days
Manchester England 5-7 days
Glasgow Scotland 5-7 days
Leeds England 5-7 days
Sheffield England 5-7 days
Liverpool England 5-7 days
Edinburgh Scotland 5-7 days
Bristol England 5-7 days
Newcastle Upon Tyne England 5-7 days
Nottingham England 5-9 days
Belfast Northern Ireland 5-9 days
Cardiff Wales 5-9 days
Leicester England 5-9 days

Related products